Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Embecta Corp. (EMBC)

$6.71 -2.19% NASDAQ: EMBC · 15-min delayed
  • PARSIPPANY, New Jersey
  • Public · NASDAQ: EMBC
  • 1,850 employees
$195.2MMarket cap
$1.1BRevenue · FY2025
$95.4MNet income
1,850Employees
EMBCNASDAQ
2022IPO

About Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$1.1B
Net income
$95.4M
Total assets
$1.1B
Market cap
$195.2M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: EMBC
$6.71 -2.19%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$2.90 $14.71

52-week range

Market cap
$195.2M
Dividend yield
0.6%
Shares outstanding
29.1M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Mar 21, 2022

Embecta Corp. (EMBC) Stock Price

  • Profitable — net income of $95.4M in FY2025.
  • Trading 54% below its 52-week high.
  • Pays a dividend yielding about 0.6% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Embecta Corp..

Write a review
Newsroom

News about Embecta Corp.

News & sentiment via Polygon.io

FAQ

Embecta Corp.: frequently asked questions

Is Embecta Corp. an American company?

Embecta Corp. is a US-based company headquartered in Parsippany, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Embecta Corp. headquartered?

Embecta Corp. is headquartered in Parsippany, New Jersey, United States.

Is Embecta Corp. publicly traded?

Yes — Embecta Corp. is a publicly traded company. Its stock trades under the ticker symbol EMBC on the NASDAQ.

What does Embecta Corp. do?

Embecta Corp. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →